AI Generated Image
Nearly 200 deaths linked to weight-loss drugs Ozempic and Mounjaro in the UK
The Times of India • • health
Key Points:
- Nearly 200 deaths in the UK have been linked to the use of anti-obesity drugs Mounjaro (tirzepatide) and Wegovy/Ozempic (semaglutide), with over 150,000 adverse side effect reports recorded.
- The UK Medicines and Healthcare Products Regulatory Agency (MHRA) reported 59 deaths associated with semaglutide, including 11 cardiac-related deaths, and 120 deaths linked to tirzepatide, with 33 caused by gastrointestinal disorders.
- The majority of adverse reactions reported for these GLP-1 weight-loss drugs are gastrointestinal disorders, with thousands of serious side effects including psychiatric and cardiac disorders also noted.
- MHRA emphasized that reported deaths and adverse reactions do not necessarily imply causation by the drugs, highlighting that underlying health conditions may contribute to these outcomes.
- Individual cases such as the deaths of Caroline Savage and Paula Owen have been linked to GLP-1 medications, drawing attention to potential risks associated with dosage increases and use.
